| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.00034 | 1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.00033 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.00032 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 9.9e-05 | 1 |